1,063
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Preparation of magnetic gelatin nanoparticles and investigating the possible use as chemotherapeutic agent

&
Pages 69-77 | Received 21 Sep 2012, Accepted 30 Oct 2012, Published online: 10 Jan 2013

References

  • Akçay G, Kılınç E, Akçay M. 2009. The equilibrium and kinetics studies of flurbiprofen adsorption onto tetrabutylammonium montmorillonite (TBAM). Colloids Surf A Physicochem Eng Asp. 335:189–193.
  • Anılanmert B, Yalcın G, Arıoz F, Dolen E. 2001. The spectrophotometric determination of cisplatin in urine, using o-phenylenediamine as derivatizing agent. Anal Lett. 34:113–123.
  • Babıncova M, Altanerova V, Altaner C, Bergemann C, Babınec P. 2008. In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia. IEEE Trans Nanobioscience. 7:15–19.
  • Balthasar S, Mıchaelıs K, Dınauer N, Von Brıesen H, Kreuter J, Langer K. 2005. Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. Biomaterials. 26:2723–2732.
  • Cafaggi S, Russo E, Stefanı R, Leardı R, Cavıglıolı G, Parodı B, . 2007. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex. J Control Release. 121:110–123.
  • Coester C, Nayyar P, Samuel J. 2006. In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation. Eur J Pharm Biopharm. 62:306–314.
  • Dıng D, Zhu Z, Lıu Q, Wang J, Hu Y, Jıang X, Lıu B. 2011. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: Synthesis, antitumor efficiency in vivo and penetration in tumors. Eur J Pharm Biopharm. 79:142–149.
  • Doan TKD, Haı TH, Phuc LH, Long BD, Vınh LK, Truc PN. 2008. Preparation and characterization of magnetic nanoparticles with chitosan coating. APCTP-ASEAN Workshop on Advanced Materials Science and Nanotechnology (AMSN08), Sep 15–21 2008 Nha Trang City, VIETNAM.
  • Gaıhre B, Aryal S, Khıl MS, Kım HY. 2008. Encapsulation of Fe3O4 in gelatin nanoparticles: Effect of different parameters on size and stability of the colloidal dispersion. J Microencapsul. 25:21–30.
  • Gaıhre B, Khıl MS, Lee DR, Kım HY. 2009. Gelatin-coated magnetic iron oxide nanoparticles as carrier system: Drug loading and in vitro drug release study. Int J Pharm. 365:180–189.
  • Ganta S, Devalapally H, Shahıwala A, Amıjı M. 2008. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release. 126:187–204.
  • Gomez-Guıllen MC, Gımenez B, Lopez-Caballero ME, Montero MP. 2011. Functional and bioactive properties of collagen and gelatin from alternative sources: a review. Food Hydrocoll25:1813–1827.
  • Jahanshahı M, Sanatı MH, Hajızadeh S, Babaeı Z. 2008. Gelatin nanoparticle fabrication and optimization of the particle size. Phys Status Solidi A. 205:2898–2902.
  • Komsapenkova R, Spırova R, Bechev B. 1996. Modification of Lowry's method for collagen concentration measurement. J Biochem Biophys Methods. 32:33–43.
  • Leo E, Vandellı MA, Cameronı R, Fornı F. 1997. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process. Int J Pharm. 155:75–82.
  • Lubbe AS, Alexıou C, Bergemann C. 2001. Clinical applications of magnetic drug targeting. J Surg Res. 95:200–206.
  • Mıttal A, Gajbe V, Mıttal J. 2008. Removal and recovery of hazardous triphenylmethane dye, Methyl Violet through adsorption over granulated waste materials. J Hazard Mater. 150:364–375.
  • Nahar M, Mıshra D, Dubey V, Jaın NK. 2008. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. Nanomed Nanotechnol Biol Med. 4:252–261.
  • Ngah WSW, Fatınathan S. 2008. Adsorption of Cu(II) ions in aqueous solution using chitosan beads, chitosan-GLA beads and chitosan-alginate beads. Chem Eng J. 143:62–72.
  • Ofokansı K, Wınter G, Frıcker G, Coester C. 2010. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery. Eur J Pharm Biopharm. 76:1–9.
  • Perez RP. 1998. Cellular and molecular determinants of cisplatin resistance. Eur J Cancer. 34:1535–1542.
  • Ramalıngam SS, Owonıkoko TK, Khurı FR. 2011. Lung cancer: new biological insights and recent therapeutic advances. CA Cancer J Clin. 61:91–112.
  • Rastogı R, Gulatı N, Kotnala RK, Sharma U, Jayasundar R, Koul V. 2011. Evaluation of folate conjugated pegylated thermosensitive magnetic nanocomposites for tumor imaging and therapy. Colloids Surf B Biointerfaces. 82:160–167.
  • Sıngh R, Lıllard JW. 2009. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 86:215–223.
  • Taherı Qazvını N, Zınatloo S. 2011. Synthesis and characterization of gelatin nanoparticles using CDI/NHS as a non-toxic cross-linking system. J Mater Sci Mater Med. 22:63–69.
  • Tseng CL, Wang TW, Dong GC, Wu SYH, Young TH, Shıeh MJ, . 2007. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. Biomaterials. 28:3996–4005.
  • Yang XQ, Chen YH, Yuan RX, Chen GH, Blanco E, Gao JM, Shuaı XT. 2008. Folate-encoded and Fe3O4-loaded polymeric micelles for dual targeting of cancer cells. Polymer. 49:3477–3485.
  • Zwıorek K, Bourquın C, Battıany J, Wınter G, Endres S, Hartmann G, Coester C. 2008. Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides. Pharm Res. 25:551–562.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.